Membership benefits

Early Access

to latest news and research articles
Members have free and unrestricted access to papers immediately after publication

Members' Services

CES offers free or discounted access to several platforms
Journal subscriptions, publication fees, annual meetings, reagents from industry partners, job postings & more


Eligibility for the Cancer Epigenetics Society Awards
Members can exclusively nominate and be recipients of the Epi Awards

Members' Resources

CES offers several resources to scientists & patients
Several cancer epigenetics databases, meetings, grant & job listings, and continuously expanding resources for scientists & patients

Our databases & journals

Our latest video

The latest news from CES databases & journals

03/13/2017- Dr. Peter Jones, Chief Scientific Officer of Van Andel Research Institute (VARI, Grand Rapids, MI, USA) is Editor-in-Chief at Cancer Epigenetics
03/09/2017- Dr. Jerry Workman, Investigator at the Stowers Institute for Medical Research (Kansas City, MO, USA) is Editor at Cancer Epigenetics
02/21/2017- Dr. Sharon Dent, Director of the Center for Cancer Epigenetics at University of Texas MD Anderson Cancer Center (Houston, TX, USA) is Editor-in-Chief at Cancer Epigenetics
01/09/2017- Dr. Tatiana Kutateladze, Professor of Pharmacology at the University of Colorado School of Medicine (Aurora, CO, USA) is Editor at Cancer Epigenetics
12/21/2016-Dr. Luciano Di Croce, Head of Epigenetics Events in Cancer Group at the Centre for Genomic Regulation (CGR) at the Barcelona Institute of Science and Technology (Barcelona, Spain) is Editor at Cancer Epigenetics

Latest Scientific Cancer Epigenetics News

Latest Medical Cancer Epigenetics News

FDA approves first colorectal cancer screening blood test: the first blood test to detect colorectal cancer approved by the US Food and Drug Administration (FDA) is a cancer epigenetics diagnostic test developed by Epigenomics AG, a German medical diagnostics company that specializes in colorectal and lung cancers. The test detects DNA methylation of Septin 9 (SEPT9), a gene on chromosome 17 whose product controls cytokinesis and cell cycle, which may serve as a tumor suppressor in ovarian cancer, and which is associated to colorectal cancer. The cancer epigenetics diagnostic test offers a minimally invasive alternative to patients who may not be comfortable undergoing a colonoscopy. The diagnostic kit dubbed Epi proColon® was already approved for use in Argentina, China, Europe, and Hong Kong (Cancer Epigenetics Society; medical news).

The Cancer Epigenetics Society in numbers

Society Members:

Continents covered
Affiliate Members
Biomedical MD/PhD Students
Biomedical MD/PhDs

Latest Cancer Epigenetics Society members

Demetria Pavlou (Research Fellow/Lecturer), Department of Life Sciences, European University Cyprus, Egkomi, Nicosia, Cyprus
Rinalda Proko (Staff Scientist), Faculty of Natural Sciences, Institute of Public Health of Albania, Tirana, Albania
Panagiotis Papageorgis (Assistant Professor), Molecular and Cellular Biology Lab, Department of Life Sciences, European University Cyprus, Egkomi, Nicosia, Cyprus
Višnja Stepanić (Professional advisor), Rudjer Boskovic Institute, Zagreb, Croatia
Meelad Dawlaty (Assistant Professor), Department of Genetics, Albert Einstein College of Medicine, New York, NY, USA
Rasmine Kalkan (Associate Professor), Department of Medical Genetics, Faculty of Medicine, Near East University, Nicosia, Cyprus
Feyza Polat (Student), Department of Molecular Biology & Genetics, Middle East Technical University, Ankara, Turkey Mushfig Orujov (Associate Professor), Department of Pathological Anatomy, Azerbaijan Medical University, Baku, Azerbaijan
Michael Bocker (Scientist), Foghorn Therapeutics, Cambridge, MA, USA
Mushfig Orujov (Associate Professor), Department of Pathological Anatomy, Azerbaijan Medical University, Baku, Azerbaijan
Greg Wang (Assistant Professor), UNC Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

Society Web Portal Contents:

Research grants
Epigenetic modifiers
Scientific meetings
Epigenetics drugs
Advocacy & Support groups
Cancers & other neoplasms
Cancer epigenetics clinical trials
Cancer cell lines
Cancer epigenetics experiments